0.1600
0.0000
(0.00%)
At close: January 29 at 3:00:00 PM EST
Breakdown
TTM
Operating Cash Flow
-10,925.8580
Investing Cash Flow
101.2550
Financing Cash Flow
11,963.1320
End Cash Position
2,852.6050
Free Cash Flow
-10,925.8580
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
AMBS Amarantus BioScience Holdings, Inc.
0.0001
0.00%
OTLC Oncotelic Therapeutics, Inc.
0.0300
+7.14%
1BT.F Enlivex Therapeutics Ltd.
1.0500
-1.87%
GYX.F Futura Medical plc
0.3500
+1.74%
PH4.MU CStone Pharmaceuticals
0.2880
0.00%
F6T.MU Fate Therapeutics Inc
1.2810
0.00%
1GDA.F Zevra Therapeutics, Inc.
7.45
0.00%
CVAC.VI CureVac N.V.
3.7580
-0.63%
HQ1.MU Oruka Therapeutics Inc. R
11.40
+1.79%
ANNX.ST Annexin Pharmaceuticals AB (publ)
0.4620
-1.70%